The emerging role of magnesium in CKD

Clin Exp Nephrol. 2022 May;26(5):379-384. doi: 10.1007/s10157-022-02182-4. Epub 2022 Jan 25.

Abstract

Increasing evidence has suggested a clinical relevance of magnesium in the context of vascular calcification and mortality among patients with CKD. Hypomagnesemia is not rare among non-dialysis CKD patients despite their decreased glomerular filtration rates; the prevalence rate was about 15% even in CKD stages G4 and G5. Among several potential causes of hypomagnesemia, tubular dysfunction/interstitial fibrosis may play a pivotal role in the development of hypomagnesemia in CKD, which impairs tubular magnesium reabsorption. Magnesium deficiency may, in turn, be involved in the progression of CKD. An in vitro study has revealed that magnesium deficiency aggravates tubular cell death and inflammation induced by phosphate load. In a cohort study of patients with CKD, low-serum magnesium levels enhanced the risk of end-stage kidney disease related to high-serum phosphate levels, suggesting a close relationship between magnesium deficiency and phosphate toxicity. More importantly, magnesium has a potent capacity to inhibit the calcification of vascular smooth muscle cells induced by phosphate. A randomized trial has shown the efficacy of oral magnesium oxide in retarding the progression of coronary artery calcification among non-dialysis CKD patients. Thus, magnesium might provide better cardiovascular prognosis; indeed, hemodialysis patients with mild hypermagnesemia exhibited the lowest mortality rate. Further randomized trials are needed to assess the impact of magnesium in terms of hard clinical outcomes among CKD patients.

Keywords: Chronic kidney disease; Fracture; Magnesium; Mortality; Phosphate; Vascular calcification.

Publication types

  • Review

MeSH terms

  • Cohort Studies
  • Disease Progression
  • Female
  • Humans
  • Magnesium
  • Magnesium Deficiency* / complications
  • Magnesium Deficiency* / drug therapy
  • Male
  • Phosphates
  • Renal Insufficiency, Chronic* / etiology
  • Vascular Calcification* / complications

Substances

  • Phosphates
  • Magnesium